Effect of low and moderate doses of recombinant human erythropoietin on the haematological response in premature infants on a high protein and iron intake


There is no consensus regarding protein intake and the doses of recombinant human erythropoietin (r-HuEpo) and iron in the treatment of anaemia of prematurity (AOP). This open, randomized study has compared the effectiveness of 50 IU r-HuEpo/kg with that of 100 IU/kg, both given subcutaneously thrice weekly. In addition, two different protein supplements… (More)
DOI: 10.1007/s004310050553

3 Figures and Tables


  • Presentations referencing similar topics